These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 26029488)
21. Differentiating Post-Polio Syndrome from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Klebek L; Sunnquist M; Jason LA Fatigue; 2019; 7(4):196-206. PubMed ID: 33014628 [TBL] [Abstract][Full Text] [Related]
22. Case definitions integrating empiric and consensus perspectives. Jason LA; McManimen S; Sunnquist M; Brown A; Furst J; Newton JL; Strand EB Fatigue; 2016; 4(1):1-23. PubMed ID: 27088059 [TBL] [Abstract][Full Text] [Related]
23. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Stevens S; Snell C; Stevens J; Keller B; VanNess JM Front Pediatr; 2018; 6():242. PubMed ID: 30234078 [No Abstract] [Full Text] [Related]
24. [Neurologic Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review]. Komaroff AL; Takahashi R; Yamamura T; Sawamura M Brain Nerve; 2018 Jan; 70(1):41-54. PubMed ID: 29348374 [TBL] [Abstract][Full Text] [Related]
25. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
26. Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms. Twisk FN World J Methodol; 2015 Jun; 5(2):68-87. PubMed ID: 26140274 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome. Maes M Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898 [TBL] [Abstract][Full Text] [Related]
28. The DePaul Symptom Questionnaire-2: A Validation Study. Bedree H; Sunnquist M; Jason LA Fatigue; 2019; 7(3):166-179. PubMed ID: 32685281 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. Haney E; Smith ME; McDonagh M; Pappas M; Daeges M; Wasson N; Nelson HD Ann Intern Med; 2015 Jun; 162(12):834-40. PubMed ID: 26075754 [TBL] [Abstract][Full Text] [Related]
30. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637 [TBL] [Abstract][Full Text] [Related]
31. Warning Signals of Post-Exertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Retrospective Analysis of 197 Patients. Ghali A; Lacout C; Ghali M; Gury A; Delattre E; Lavigne C; Urbanski G J Clin Med; 2021 Jun; 10(11):. PubMed ID: 34200126 [TBL] [Abstract][Full Text] [Related]
32. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS). Morris G; Maes M Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418 [TBL] [Abstract][Full Text] [Related]
33. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data. Maes M; Twisk FN; Johnson C Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895 [TBL] [Abstract][Full Text] [Related]
34. Defining Essential Features of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Jason LA; Sunnquist M; Brown A; Reed J J Hum Behav Soc Environ; 2015; 25(6):657-674. PubMed ID: 27047234 [TBL] [Abstract][Full Text] [Related]
35. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Johnston SC; Staines DR; Marshall-Gradisnik SM Clin Epidemiol; 2016; 8():97-107. PubMed ID: 27279748 [TBL] [Abstract][Full Text] [Related]
36. Myalgic encephalomyelitis and chronic fatigue syndrome case definitions: effects of requiring a substantial reduction in functioning. Scartozzi S; Sunnquist M; Jason LA Fatigue; 2019; 7(2):59-68. PubMed ID: 31788347 [TBL] [Abstract][Full Text] [Related]
38. Test-Retest Reliability of the DePaul Symptom Questionnaire. Jason LA; So S; Brown AA; Sunnquist M; Evans M Fatigue; 2015 Jan; 3(1):16-32. PubMed ID: 26973799 [TBL] [Abstract][Full Text] [Related]
39. Deconstructing post-exertional malaise: An exploratory factor analysis. McManimen SL; Sunnquist ML; Jason LA J Health Psychol; 2019 Feb; 24(2):188-198. PubMed ID: 27557649 [TBL] [Abstract][Full Text] [Related]
40. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]